Leukemic Stem Cells: From Leukemic Niche Biology to Treatment Opportunities - Université de Rennes Accéder directement au contenu
Article Dans Une Revue Frontiers in Immunology Année : 2021

Leukemic Stem Cells: From Leukemic Niche Biology to Treatment Opportunities

Résumé

Acute myeloid leukemia (AML) is one of the most common types of leukemia in adults. While complete remission can be obtained with intensive chemotherapy in young and fit patients, relapse is frequent and prognosis remains poor. Leukemic cells are thought to arise from a pool of leukemic stem cells (LSCs) which sit at the top of the hierarchy. Since their discovery, more than 30 years ago, LSCs have been a topic of intense research and their identification paved the way for cancer stem cell research. LSCs are defined by their ability to self-renew, to engraft into recipient mice and to give rise to leukemia. Compared to healthy hematopoietic stem cells (HSCs), LSCs display specific mutations, epigenetic modifications, and a specific metabolic profile. LSCs are usually considered resistant to chemotherapy and are therefore the drivers of relapse. Similar to their HSC counterpart, LSCs reside in a highly specialized microenvironment referred to as the "niche". Bidirectional interactions between leukemic cells and the microenvironment favor leukemic progression at the expense of healthy hematopoiesis. Within the niche, LSCs are thought to be protected from genotoxic insults. Improvement in our understanding of LSC gene expression profile and phenotype has led to the development of prognosis signatures and the identification of potential therapeutic targets. In this review, we will discuss LSC biology in the context of their specific microenvironment and how a better understanding of LSC niche biology could pave the way for new therapies that target AML.
Fichier principal
Vignette du fichier
Marchand.pdf (3.74 Mo) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-03423354 , version 1 (02-06-2022)

Licence

Paternité

Identifiants

Citer

Tony Marchand, Sandra Pinho. Leukemic Stem Cells: From Leukemic Niche Biology to Treatment Opportunities. Frontiers in Immunology, 2021, 12, pp.775128. ⟨10.3389/fimmu.2021.775128⟩. ⟨hal-03423354⟩
16 Consultations
22 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More